Position in ABBV
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$732,272
+$123,300 QoQ
Shares Held
2,910
+3.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#2,841
of 4,153 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Tempo Wealth, LLC holds $8,612,005 across 7 Drug Manufacturers - General names. ABBV ranks #3 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
17,957 | $4,560,539 | |
| 2 | LLY |
ELI LILLY & Co
|
1,325 | $1,589,244 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
2,910 | $732,272 | |
| 4 | AMGN |
Amgen Inc
|
1,945 | $704,323 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,405 | $566,042 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,937 | $244,720 | |
| 7 | PFE |
Pfizer Inc
|
8,923 | $214,865 |
All Filings in ABBV
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $732,272 | 2,910 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $608,972 | 2,800 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $627,205 | 2,745 | Shares | Sole | 2026-02-25 | |
| No filing history on record for this holder in this stock. | ||||||